Reduced
0.55% → 0.54%
Oaktree Capital sold 4,135,000 shares; portfolio weight moved from 0.55% to 0.54%.
-4,135,000 Shares
-10.25%
CONMED CORP is tracked here as a normalized 13F company record; no curated business description is available yet.
Original CUSIPs: 207410AH4. This page shows current managers, quarterly changes, and primary SEC sources.
Portfolio weight and share-count changes are shown for every tracked manager with a current or prior-quarter position.
Oaktree Capital sold 4,135,000 shares; portfolio weight moved from 0.55% to 0.54%.
Each line is one tracked manager’s portfolio weight. Labels identify the manager directly.
Market values, quarterly totals, and original CUSIP rows are available below without obscuring current actions.
| Quarter | Current managers | Combined value | Total shares | Manager details |
|---|---|---|---|---|
| Q2 2025 | 1 | $26,318,850 | 27,705,000 | Oaktree Capital New position · 27,705,000 Shares |
| Q3 2025 | 1 | $38,649,661 | 40,513,000 | Oaktree Capital Increased · 40,513,000 Shares |
| Q4 2025 | 1 | $38,711,039 | 40,324,000 | Oaktree Capital Reduced · 40,324,000 Shares |
| Q1 2026 | 1 | $35,121,424 | 36,189,000 | Oaktree Capital Reduced · 36,189,000 Shares |
| Manager | Issuer | CUSIP | Security class | Market value | Shares | Weight | Source |
|---|---|---|---|---|---|---|---|
| Oaktree Capital | CONMED CORP | 207410AH4 | CONVERTIBLE BOND | $35,121,424 | 36,189,000 | 0.54% | SEC XML |